Statement of Deviation & Variation for the quarter ended September 30, 2026

Ref: BHL/ STEX 46/ 2026-27 Date: October 17, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers 5th Floor, Exchange Plaza, Dalal Street Bandra Kurla Complex Bandra (East) Mumbai – 400 001 Mumbai-400051 Scrip Code: 539872 Symbol: BAJAJHCARE Sub: Statement of deviation or variation in the use of proceeds raised through Preferential Issue Dear Sir/Madam, Pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Statement of Deviation or Variation for the Quarter ended September 30, 2026 confirming that there is no deviation or variation in the utilisation of proceeds raised through the allotment of Equity Shares pursuant to the exercise of options for conversion of convertible warrants into equity shares. The Statement of Deviation or Variation duly reviewed by the Audit Committee, is enclosed herewith as “Annexure A”. Please take the same on record. Thanking you. Yours faithfully, For and on behalf of Bajaj Healthcare Limited Monica Tanwar Company Secretary & Compliance Officer Encl: as above BAJAJ HEALTHCARE LIMITED Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604 Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : bajajhealth@bajajhealth.com CIN No. L99999MH1993PLC072892